J.P. Morgan Lowers Gilead Sciences to 'Neutral'

After a strong first half, analyst David Molowa thinks it will be tougher for Gilead to beat consensus forecasts going forward

J.P. Morgan downgraded Gilead Sciences (GILD ) to neutral from overweight.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.